HEADER TRANSFERASE 03-AUG-21 7PCD TITLE HER2 IN COMPLEX WITH A COVALENT INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NONE; COMPND 5 SYNONYM: METASTATIC LYMPH NODE GENE 19 PROTEIN,MLN 19,PROTO-ONCOGENE COMPND 6 NEU,PROTO-ONCOGENE C-ERBB-2,TYROSINE KINASE-TYPE CELL SURFACE COMPND 7 RECEPTOR HER2,P185ERBB2; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERBB2, HER2, MLN19, NEU, NGL; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS HER2, COVALENT INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.BADER REVDAT 3 31-JAN-24 7PCD 1 REMARK REVDAT 2 10-AUG-22 7PCD 1 JRNL REVDAT 1 27-JUL-22 7PCD 0 JRNL AUTH B.WILDING,D.SCHARN,D.BOSE,A.BAUM,V.SANTORO,P.CHETTA, JRNL AUTH 2 R.SCHNITZER,D.A.BOTESTEANU,C.REISER,S.KORNIGG,P.KNESL, JRNL AUTH 3 A.HORMANN,A.KOFERLE,M.CORCOKOVIC,S.LIEB,G.SCHOLZ, JRNL AUTH 4 J.BRUCHHAUS,M.SPINA,J.BALLA,B.PERIC-SIMOV,J.ZIMMER, JRNL AUTH 5 S.MITZNER,T.N.FETT,A.BERAN,L.LAMARRE,T.GERSTBERGER, JRNL AUTH 6 D.GERLACH,M.BAUER,A.BERGNER,A.SCHLATTL,G.BADER,M.TREU, JRNL AUTH 7 H.ENGELHARDT,S.ZAHN,J.E.FUCHS,J.ZUBER,P.ETTMAYER,M.PEARSON, JRNL AUTH 8 M.PETRONCZKI,N.KRAUT,D.B.MCCONNELL,F.SOLCA,R.A.NEUMULLER JRNL TITL DISCOVERY OF POTENT AND SELECTIVE HER2 INHIBITORS WITH JRNL TITL 2 EFFICACY AGAINST HER2 EXON 20 INSERTION-DRIVEN TUMORS, WHICH JRNL TITL 3 PRESERVE WILD-TYPE EGFR SIGNALING. JRNL REF NAT CANCER V. 3 821 2022 JRNL REFN ESSN 2662-1347 JRNL PMID 35883003 JRNL DOI 10.1038/S43018-022-00412-Y REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 22352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2495 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.77 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1654 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.4330 REMARK 3 BIN FREE R VALUE SET COUNT : 185 REMARK 3 BIN FREE R VALUE : 0.4450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2176 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.12000 REMARK 3 B22 (A**2) : -3.19000 REMARK 3 B33 (A**2) : -2.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.161 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.144 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.144 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.201 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2254 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2223 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3062 ; 1.438 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5089 ; 1.191 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 272 ; 5.906 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 91 ;35.267 ;22.198 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 406 ;12.164 ;15.135 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;12.738 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 344 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2465 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 503 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7PCD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1292117459. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24847 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 61.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.43800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.190 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3RCD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 50MM AMMONIUM TARTRATE, REMARK 280 150MM SODIUM TARTRATE AND 100MM BIS-TRIS, PH 6.75, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.00450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.16250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.23550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.16250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.00450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.23550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 703 REMARK 465 GLY A 704 REMARK 465 ALA A 705 REMARK 465 ALA A 706 REMARK 465 PRO A 707 REMARK 465 ASN A 708 REMARK 465 GLN A 709 REMARK 465 GLU A 874 REMARK 465 THR A 875 REMARK 465 GLU A 876 REMARK 465 TYR A 877 REMARK 465 HIS A 878 REMARK 465 ALA A 879 REMARK 465 ASP A 880 REMARK 465 GLY A 881 REMARK 465 GLY A 882 REMARK 465 LYS A 883 REMARK 465 GLU A 992 REMARK 465 ASP A 993 REMARK 465 LEU A 994 REMARK 465 GLY A 995 REMARK 465 PRO A 996 REMARK 465 ALA A 997 REMARK 465 SER A 998 REMARK 465 PRO A 999 REMARK 465 LEU A 1000 REMARK 465 ASP A 1001 REMARK 465 SER A 1002 REMARK 465 THR A 1003 REMARK 465 PHE A 1004 REMARK 465 TYR A 1005 REMARK 465 ARG A 1006 REMARK 465 SER A 1007 REMARK 465 LEU A 1008 REMARK 465 LEU A 1009 REMARK 465 GLU A 1010 REMARK 465 ASP A 1011 REMARK 465 ASP A 1012 REMARK 465 ASP A 1013 REMARK 465 MET A 1014 REMARK 465 GLY A 1015 REMARK 465 ASP A 1016 REMARK 465 LEU A 1017 REMARK 465 VAL A 1018 REMARK 465 ASP A 1019 REMARK 465 ALA A 1020 REMARK 465 GLU A 1021 REMARK 465 GLU A 1022 REMARK 465 TYR A 1023 REMARK 465 LEU A 1024 REMARK 465 VAL A 1025 REMARK 465 PRO A 1026 REMARK 465 GLN A 1027 REMARK 465 GLN A 1028 REMARK 465 GLY A 1029 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 757 CD OE1 OE2 REMARK 480 ASN A 758 CG OD1 ND2 REMARK 480 LYS A 762 CE NZ REMARK 480 GLU A 766 CG CD OE1 OE2 REMARK 480 LYS A 854 NZ REMARK 480 ARG A 868 CG CD NE CZ NH1 NH2 REMARK 480 ASP A 871 CG OD1 OD2 REMARK 480 ASP A 873 CG OD1 OD2 REMARK 480 LYS A 921 CE NZ REMARK 480 LYS A 957 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 774 53.66 -91.46 REMARK 500 THR A 791 -141.71 -105.18 REMARK 500 ARG A 844 -1.85 76.42 REMARK 500 ASP A 845 43.91 -161.56 REMARK 500 ILE A 872 -39.64 114.10 REMARK 500 ASP A 982 64.98 -156.55 REMARK 500 ASP A 982 64.98 -156.69 REMARK 500 REMARK 500 REMARK: NULL DBREF 7PCD A 703 1029 UNP P04626 ERBB2_HUMAN 703 1029 SEQADV 7PCD ALA A 706 UNP P04626 MET 706 CONFLICT SEQADV 7PCD LEU A 711 UNP P04626 GLN 711 CONFLICT SEQADV 7PCD LEU A 712 UNP P04626 MET 712 CONFLICT SEQRES 1 A 327 SER GLY ALA ALA PRO ASN GLN ALA LEU LEU ARG ILE LEU SEQRES 2 A 327 LYS GLU THR GLU LEU ARG LYS VAL LYS VAL LEU GLY SER SEQRES 3 A 327 GLY ALA PHE GLY THR VAL TYR LYS GLY ILE TRP ILE PRO SEQRES 4 A 327 ASP GLY GLU ASN VAL LYS ILE PRO VAL ALA ILE LYS VAL SEQRES 5 A 327 LEU ARG GLU ASN THR SER PRO LYS ALA ASN LYS GLU ILE SEQRES 6 A 327 LEU ASP GLU ALA TYR VAL MET ALA GLY VAL GLY SER PRO SEQRES 7 A 327 TYR VAL SER ARG LEU LEU GLY ILE CYS LEU THR SER THR SEQRES 8 A 327 VAL GLN LEU VAL THR GLN LEU MET PRO TYR GLY CYS LEU SEQRES 9 A 327 LEU ASP HIS VAL ARG GLU ASN ARG GLY ARG LEU GLY SER SEQRES 10 A 327 GLN ASP LEU LEU ASN TRP CYS MET GLN ILE ALA LYS GLY SEQRES 11 A 327 MET SER TYR LEU GLU ASP VAL ARG LEU VAL HIS ARG ASP SEQRES 12 A 327 LEU ALA ALA ARG ASN VAL LEU VAL LYS SER PRO ASN HIS SEQRES 13 A 327 VAL LYS ILE THR ASP PHE GLY LEU ALA ARG LEU LEU ASP SEQRES 14 A 327 ILE ASP GLU THR GLU TYR HIS ALA ASP GLY GLY LYS VAL SEQRES 15 A 327 PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU ARG ARG SEQRES 16 A 327 ARG PHE THR HIS GLN SER ASP VAL TRP SER TYR GLY VAL SEQRES 17 A 327 THR VAL TRP GLU LEU MET THR PHE GLY ALA LYS PRO TYR SEQRES 18 A 327 ASP GLY ILE PRO ALA ARG GLU ILE PRO ASP LEU LEU GLU SEQRES 19 A 327 LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR ILE SEQRES 20 A 327 ASP VAL TYR MET ILE MET VAL LYS CYS TRP MET ILE ASP SEQRES 21 A 327 SER GLU CYS ARG PRO ARG PHE ARG GLU LEU VAL SER GLU SEQRES 22 A 327 PHE SER ARG MET ALA ARG ASP PRO GLN ARG PHE VAL VAL SEQRES 23 A 327 ILE GLN ASN GLU ASP LEU GLY PRO ALA SER PRO LEU ASP SEQRES 24 A 327 SER THR PHE TYR ARG SER LEU LEU GLU ASP ASP ASP MET SEQRES 25 A 327 GLY ASP LEU VAL ASP ALA GLU GLU TYR LEU VAL PRO GLN SEQRES 26 A 327 GLN GLY HET 70I A1101 45 HETNAM 70I 1-[4-[4-[[3,5-BIS(CHLORANYL)-4-([1,2,4]TRIAZOLO[1,5- HETNAM 2 70I A]PYRIDIN-7-YLOXY)PHENYL]AMINO]PYRIMIDO[5,4- HETNAM 3 70I D]PYRIMIDIN-6-YL]PIPERAZIN-1-YL]-4-(3- HETNAM 4 70I FLUORANYLAZETIDIN-1-YL)BUTAN-1-ONE FORMUL 2 70I C29 H28 CL2 F N11 O2 FORMUL 3 HOH *108(H2 O) HELIX 1 AA1 LYS A 716 THR A 718 5 3 HELIX 2 AA2 SER A 760 MET A 774 1 15 HELIX 3 AA3 CYS A 805 ASN A 813 1 9 HELIX 4 AA4 GLY A 818 VAL A 839 1 22 HELIX 5 AA5 ALA A 847 ARG A 849 5 3 HELIX 6 AA6 PRO A 885 MET A 889 5 5 HELIX 7 AA7 ALA A 890 ARG A 897 1 8 HELIX 8 AA8 THR A 900 THR A 917 1 18 HELIX 9 AA9 PRO A 927 ARG A 929 5 3 HELIX 10 AB1 GLU A 930 GLY A 938 1 9 HELIX 11 AB2 THR A 948 TRP A 959 1 12 HELIX 12 AB3 ASP A 962 ARG A 966 5 5 HELIX 13 AB4 ARG A 968 ARG A 981 1 14 HELIX 14 AB5 ASP A 982 VAL A 987 1 6 SHEET 1 AA1 5 LEU A 720 SER A 728 0 SHEET 2 AA1 5 GLY A 732 TRP A 739 -1 O LYS A 736 N LYS A 724 SHEET 3 AA1 5 ILE A 748 LEU A 755 -1 O ILE A 748 N TRP A 739 SHEET 4 AA1 5 VAL A 794 GLN A 799 -1 O LEU A 796 N LYS A 753 SHEET 5 AA1 5 LEU A 785 LEU A 790 -1 N CYS A 789 O GLN A 795 SHEET 1 AA2 2 VAL A 851 SER A 855 0 SHEET 2 AA2 2 HIS A 858 ILE A 861 -1 O LYS A 860 N LEU A 852 LINK SG CYS A 805 C7 70I A1101 1555 1555 1.82 CRYST1 34.009 94.471 80.325 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029404 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010585 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012449 0.00000